APA (7th ed.) Citation

Bresson, D., & von Herrath, M. (2011). Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model. Clinical and experimental immunology, 163(3), 375-380. https://doi.org/10.1111/j.1365-2249.2010.04304.x

Chicago Style (17th ed.) Citation

Bresson, D., and M.G von Herrath. "Anti-thymoglobulin (ATG) Treatment Does Not Reverse Type 1 Diabetes in the Acute Virally Induced Rat Insulin Promoter-lymphocytic Choriomeningitis Virus (RIP-LCMV) Model." Clinical and Experimental Immunology 163, no. 3 (2011): 375-380. https://doi.org/10.1111/j.1365-2249.2010.04304.x.

MLA (9th ed.) Citation

Bresson, D., and M.G von Herrath. "Anti-thymoglobulin (ATG) Treatment Does Not Reverse Type 1 Diabetes in the Acute Virally Induced Rat Insulin Promoter-lymphocytic Choriomeningitis Virus (RIP-LCMV) Model." Clinical and Experimental Immunology, vol. 163, no. 3, 2011, pp. 375-380, https://doi.org/10.1111/j.1365-2249.2010.04304.x.